Purdue Liste PDF
Purdue Liste PDF
Purdue Liste PDF
Buprenorphine Codeine Codeine Fentanyl Fentanyl Prescription Opioid** Analgesics and Stimulants Fentanyl Hydrocodone Hydromorphone
Marketed in Canada
MS•IR® Cesamet® Zytram XL® Ritalin®
Teva-Morphine SR 5 mg Concerta®
0.25 mg 50 mg 75 mg 10 mg
5 mg 100 mg 18 mg
Adderall XR®
Cesamet® © Photos are copyright of Purdue Pharma and may not be reproduced in any format without written permission. 10 mg Ritalin®
MS•IR® 0.5 mg Tapentadol Zytram XL® 20 mg
10 mg Pamphlet is posted on www.purdue.ca 100 mg Adderall XR® Concerta®
Teva-Morphine SR Cesamet® Nucynta® IR 15 mg Apo-Methylphenidate 27 mg
MS•IR® 200 mg 1 mg 50 mg
Zytram XL® 5 mg
20 mg Oxycodone Oxycodone Oxycodone Oxycodone Nucynta® IR 150 mg
Adderall XR®
20 mg
ACT Nabilone 75 mg Apo-Methylphenidate
MS•IR® Kadian® 10 mg 0.5 mg pms-Oxycodone pms-Oxycodone CR Zytram XL® Adderall XR® 10 mg Concerta®
Apo-Oxycodone CR Targin® Nucynta® IR
30 mg 5 mg 40 mg 200 mg 25 mg 36 mg
ACT Nabilone 5 mg 5 mg/2.5 mg 100 mg Apo-Methylphenidate
Kadian® 20 mg 1 mg 20 mg
Statex Zytram XL® Adderall XR®
5 mg Apo-Oxycodone CR pms-Oxycodone CR 300 mg 30 mg
pms-Nabilone pms-Oxycodone Targin® pms-Methylphenidate
Kadian® 50 mg 10 mg 80 mg Concerta®
Statex 0.5 mg 10 mg 10 mg/5 mg Nucynta® Extended-release 50 mg ACT Amphetamine XR 5 mg
Zytram XL® 5 mg 54 mg
10 mg pms-Nabilone Apo-Oxycodone CR
Kadian® 100 mg 400 mg pms-Methylphenidate
1 mg ACT Amphetamine XR
Statex 15 mg OxyNEO® Nucynta® Extended-release 100 mg 10 mg 10 mg
pms-Oxycodone 10 mg Targin® Ultram®
25 mg RanTM -Nabilone 50 mg ACT Amphetamine XR pms-Methylphenidate
M-Eslon® 10 mg 20 mg 20 mg/10 mg
0.25 mg Apo-Oxycodone CR 15 mg 20 mg pms-Methylphenidate ER
Statex Apo-Tramadol 18 mg
20 mg Nucynta® Extended-release 150 mg 50 mg ACT Amphetamine XR
50 mg M-Eslon® 15 mg RanTM -Nabilone OxyNEO®
20 mg ratio-Methylphenidate
0.5 mg 15 mg
ACT Oxycodone CR Apo-Oxycodone CR Targin® Tramacet® ACT Amphetamine XR 5 mg
MS Contin® 40 mg/20 mg
M-Eslon® 30 mg RanTM -Nabilone 5 mg 30 mg 37.5 mg/325 mg* 25 mg
15 mg OxyNEO® Nucynta® Extended-release 200 mg ratio-Methylphenidate pms-Methylphenidate ER
1 mg
20 mg ACT Amphetamine XR 10 mg 27 mg
MS Contin® M-Eslon® 60 mg Apo-Oxycodone CR 30 mg
Teva-Nabilone ACT Oxycodone CR ACT Tramadol/Acet
30 mg 40 mg ratio-Methylphenidate
Presented as an educational service by 0.25 mg 10 mg 37.5 mg/325 mg*
Purdue Pharma MS Contin®
M-Eslon® 100 mg OxyNEO® Percocet®* Nucynta® Extended-release 250 mg Dextroamphetamine 20 mg
Teva-Nabilone Apo-Oxycodone CR 30 mg 5 mg Ritalin® SR
60 mg 0.5 mg Dexedrine® pms-Methylphenidate ER
60 mg
ENDORSED BY M-Eslon® 200 mg
Teva-Nabilone
ACT Oxycodone CR Tramadol Apo-Tramadol/Acet 5 mg
20 mg
36 mg
MS Contin® 20 mg Percocet® Demi* 37.5 mg /325 mg* Apo-Methylphenidate
1 mg OxyNEO® DurelaTM Apo Dextroamphetamine
100 mg Apo-Oxycodone CR 2.5 mg SR 20 mg
M.O.S.®-Sulfate 5 40 mg 100 mg
80 mg 5 mg
5 mg Jamp-Acet-Tramadol Sandoz Methylphenidate
M.O.S.®-Sulfate 10 Oxycodone ACT Oxycodone CR
OxyNEO®
DurelaTM
200 mg 37.5 mg/325 mg* Dexedrine® SR 20 mg pms-Methylphenidate ER
MS Contin® 40 mg pms-Oxycodone CR
10 mg 60 mg Endocet®* Spansule 10 mg 54 mg
200 mg Oxy•IR® 10 mg Biphentin®
M.O.S.®-Sulfate 25 5 mg DurelaTM
5 mg 300 mg 10 mg
25 mg Mint-Tramadol/Acet Dexedrine®
Sandoz Morphine SR ACT Oxycodone CR pms-Oxycodone CR OxyNEO® 37.5 mg/325 mg* Biphentin®
M.O.S.®-Sulfate 50 Oxy•IR® Apo-Oxycodone- Raliva TM Spansule 15 mg
15 mg 80 mg 20 mg 80 mg 15 mg
50 mg 10 mg Acetaminophen* 100 mg Teva-Methylphenidate
Biphentin® ER-C 18 mg
Sandoz Morphine SR M.O.S.® 10
5 mg RalivaTM Mylan-Tramadol/Acet Lisdexamfetamine 20 mg
For more information 30 mg 10 mg Oxy•IR® Notice: While every effort has been made to depict these drugs in an accurate manner, variations in colour may exist because of the 200 mg 37.5 mg/ 325 mg* Vyvanse®
photographic reproduction and printing processes. This information is not guaranteed to be error-free and is presented for informational Biphentin®
M.O.S.® 20 20 mg pms-Oxycodone- RalivaTM 10 mg Teva-Methylphenidate
on pain management, visit Sandoz Morphine SR
20 mg and educational purposes only. In addition, manufacturers may from time to time change the appearance of their products, subject to Acetaminophen* 300 mg Vyvanse®
30 mg
60 mg pms-Tramadol-Acet ER-C 27 mg
M.O.S.® 40 Canadian regulatory requirements. The pamphlet attempts to summarize the marketed tablet/capsule/patch opioid/stimulant products, 5 mg 20 mg Biphentin®
www.purdue.ca but may not be all inclusive. It is noted that there may be other opioid/stimulant brands marketed from time to time that are not shown Tridural®
37.5 mg/325 mg*
40 mg
40 mg Supeudol® Vyvanse®
Teva-Morphine SR in this pamphlet. Positive identification of any drug requires analysis by an authorized laboratory. All trademarks mentioned in this 100 mg 30 mg
M.O.S.® 60 5 mg ratio-Oxycocet* Biphentin® Teva-Methylphenidate
15 mg pamphlet are the property of their respective owners. ER-C 36 mg
60 mg 5 mg RanTM -Tramadol/Acet Vyvanse® 50 mg
* Combination Preparation — contains opioid and non-opioid drug substance(s). Tridural®
Supeudol® 37.5 mg/325 mg* 40 mg
Teva-Morphine SR M.O.S.-SR® ** Opioid refers broadly to all compounds related to opium. 200 mg Biphentin®
10 mg ¶ Not shown actual size. February 2016 Vyvanse®
Purdue Pharma Inc. 30 mg 30 mg 60 mg
General Partner of / commandité de ratio-Oxycodan* 50 mg Teva-Methylphenidate
Supeudol® Tridural® Teva-Tramadol/Acet ER-C 54 mg
Teva-Morphine SR M.O.S.-SR® 5 mg Biphentin®
Purdue Pharma 60 mg 60 mg 20 mg Pamphlet is posted on www.purdue.ca 300 mg 37.5 mg/325 mg* Vyvanse®
80 mg
Pickering, Ontario L1W 3W8 60 mg